Loading stock data…
$1.80-0.05 (-2.74%)
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America.
Biomerica, Inc. in the Healthcare sector is trading at $1.80 with a market capitalization of $12M. The stock is currently near its 52-week low of $1.45, remaining 14.3% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 17 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $875,000↓ | $987,000↓ | $1.21M↓ | $1.38M↑ | $749,000 |
| Gross Profit | -$71,000↓ | -$44,000↓ | $51,000↓ | $424,000↑ | -$244,000 |
| Operating Income | -$1.53M↓ | -$1.30M↑ | -$1.37M↓ | -$1.12M↑ | -$1.56M |
| Net Income | -$1.15M↑ | -$1.31M↑ | -$1.32M↓ | $2,000↑ | -$1.54M |
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe,...